Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 319,172 | 67,697 | 65,624 | N/A | N/A |
| TOTAL | $320,132 | $68,740 | $66,553 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,403 | 1,334 | 1,272 | N/A | N/A |
| Other Non-Current Assets | 1,575 | 3,315 | 1,575 | 0 | 0 |
| TOTAL | $2,978 | $4,649 | $2,847 | $N/A | $N/A |
| Total Assets | $323,110 | $73,389 | $69,400 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 703 | 2,890 | 830 | 0 | 0 |
| Accrued Expenses | 6,629 | 3,727 | 3,326 | N/A | N/A |
| TOTAL | $7,610 | $6,795 | $4,273 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 293 | 111,328 | 98,587 | 0 | 0 |
| TOTAL | $293 | $111,328 | $98,615 | $N/A | $N/A |
| Total Liabilities | $7,903 | $118,123 | $102,888 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,664 | N/A | N/A | N/A | N/A |
| Retained earnings | -89,825 | -45,092 | -34,774 | N/A | N/A |
| TOTAL | $315,207 | $-44,734 | $-33,488 | $N/A | $N/A |
| Total Liabilities And Equity | $323,110 | $73,389 | $69,400 | $0 | $0 |